2021
DOI: 10.15761/rom.1000189
|View full text |Cite
|
Sign up to set email alerts
|

Progress and prospects of biologics and small molecules for the treatment of patients with systemic lupus erythematosus

Abstract: Due to the complexity of the pathogenesis of systemic lupus erythematosus (SLE), the research and development of drugs targeting different pathogenesis or targets of SLE and their application in clinical treatment will be a major topic at present and in the future. According to the existing viewpoints and the latest research results from basic to clinical, new breakthroughs may occur in the research, development, and application of drugs, including drugs targeting B cells, T cells, long-lived plasma cells (LLP… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 74 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?